Lexington, KY, United States of America

Andre T Baron


Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Rochester, MN (US) (2010)
  • Lexington, KY (US) (2011 - 2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andre T. Baron

Introduction

Andre T. Baron is a notable inventor based in Lexington, KY (US), recognized for his contributions to the field of cancer research. He holds three patents that focus on innovative biomarkers and therapeutic methods for cancer detection and treatment. His work has significant implications for improving patient outcomes in oncology.

Latest Patents

One of his latest patents is related to biomarkers for ovarian cancer. This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. The biomarkers can classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease, or other malignant conditions. They can be detected by SELDI mass spectrometry, offering a novel approach to cancer diagnostics.

Another significant patent involves soluble epidermal growth factor receptor isoforms. This invention relates to p110 soluble EGFR (p110 sEGFR) peptides and nucleic acid sequences. It discloses antibodies, methods of detection, kits, and expression vectors for p110 sEGFR. Additionally, it includes assays on biological samples for determining and evaluating risk assessment and cancer prevention, screening, early detection, diagnosis, prognosis, theragnosis, and monitoring of cancer progression. The findings suggest that a lower p110 sEGFR concentration, adjusted for demographic and physiological variables, is associated with cancer.

Career Highlights

Throughout his career, Andre T. Baron has worked with various organizations, including Tumor Biology Investment Group, Inc. and Vermillion Corporation. His experience in these companies has allowed him to advance his research and contribute to significant innovations in cancer diagnostics and treatment.

Collaborations

Andre has collaborated with notable professionals in his field, including Nita J. Maihle and Eric Thomas Fung. These collaborations have further enriched his research and development efforts.

Conclusion

Andre T. Baron is a distinguished inventor whose work in cancer biomarkers and therapeutic methods has the potential to transform patient care in oncology. His innovative patents and collaborations highlight his commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…